本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Anaptysbio Inc

55.06
+0.75001.38%
盤後55.060.00000.00%19:30 EDT
成交量:43.96萬
成交額:2,416.80萬
市值:16.30億
市盈率:-60.86
高:55.79
開:55.09
低:54.49
收:54.31
52周最高:73.30
52周最低:19.47
股本:2,960.85萬
流通股本:2,104.51萬
量比:1.21
換手率:2.09%
股息:- -
股息率:- -
每股收益(TTM):-0.9047
每股收益(LYR):-0.4601
淨資產收益率:-114.55%
總資產收益率:6.78%
市淨率:127.89
市盈率(LYR):-119.67

資料載入中...

2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

重要事件披露

8-K - Current report
2021/01/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/17

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report